Jump to content
RemedySpot.com

Diabetes Drug Could Cause Pancreatic Cancer

Rate this topic


Guest guest

Recommended Posts

Not good.

Do one thing every day that scares you.

Eleanor Roosevelt

From: berrgas <berrgas@...>Flu Sent: Friday, October 2, 2009 5:39:55 AMSubject: [Flu] Diabetes Drug Could Cause Pancreatic Cancer

The popular diabetes drug sitagliptin (marketed as Januvia) may increase the risk of pancreatic cancer, according to study conducted by researchers from the University of California-Los Angeles and published in the journal Diabetes Read more at http://healtnhappyn ess.blogspot. com/

Link to comment
Share on other sites

>

> The popular diabetes drug sitagliptin (marketed as Januvia) may

increase

> the risk of pancreatic cancer

Your typical run of the mill drugs aren't going to do much for chronic

diseases, except likely to cause other serious problems long time.

Probably one of the best ways to control diabetes and/or cure it would

be a low-carbohydrate, ketogenic (high fat) diet, especially following

Weston A Price principles.

http://srv9.louhi.net/anttiheikkila.com/liitteet/173-7052-2-34.pdf

A low-carbohydrate, ketogenic diet to treat type 2 diabetes

Abstract

Background: The low-carbohydrate, ketogenic diet (LCKD) may be effective

for improving glycemia and reducing medications in patients with type 2

diabetes.

Methods: From an outpatient clinic, we recruited 28 overweight

participants with type 2 diabetes for a 16-week single-arm pilot diet

intervention trial. We provided LCKD counseling, with an initial goal of

<20 g carbohydrate/day, while reducing diabetes medication dosages at

diet initiation. Participants returned every other week for

measurements, counseling, and further medication adjustment. The primary

outcome was hemoglobin A1c.

Results: 21 of the 28 participants who were enrolled completed the

study. The mean age was 56 years and BMI was 42.2 kg/m2. Hemoglobin A1c

decreased by 16% from 7.5% to 6.3% from baseline to week 16. Diabetes

medications were discontinued in 7 participants, reduced in 10

participants, and unchanged in 4 participants. The mean body weight

decreased by 6.6% from 131.4 kg to 122.7 kg. Weight change at 16 weeks

did not predict change in hemoglobin A1c. FASTING SERUM TRIGLYCERIDE

DECREASED 42% while other serum lipid measurements did not change

significantly.

Conclusion: The LCKD improved glycemic control in patients with type 2

diabetes such that diabetes medications were discontinued or reduced in

most participants. Because the LCKD can be VERY EFFECTIVE at lowering

blood glucose, patients on diabetes medication who use this diet should

be under close medical supervision or CAPABLE OF ADJUSTING THEIR

MEDICATION.

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...